Howe & Rusling’s ARK Genomic Revolution ETF ARKG Stock Holding History

Howe & Rusling’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40	Closed	-$2K	–	1050
2022 Q1	$2K	Buy	+40	New	+$1.91K	﹤0.01%	833
2021 Q4	–	Sell	-87	Closed	-$7K	–	986
2021 Q3	$7K	Buy	87 +75	+625%	+$6.29K	﹤0.01%	560
2021 Q2	$1K	Hold	12	–	–	﹤0.01%	858
2021 Q1	$1K	Hold	12	–	–	﹤0.01%	867
2020 Q4	$1K	Buy	+12	New	+$956	﹤0.01%	856

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Howe & Rusling's ARKG Position: Q2 2022 in Review

Howe & Rusling sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 40 shares — an estimated $2K sold.

Howe & Rusling first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $7K in Q3 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Howe & Rusling reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Howe & Rusling sold 40 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $2K.
Howe & Rusling first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
Howe & Rusling's ARK Genomic Revolution ETF position peaked at $7K in Q3 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.